The Pharmacogenetics of Aripiprazole-Induced Hyperprolactinemia: What Do We Know?

References

• Di Sciascio G , RivaMA. Aripiprazole: from pharmacological profile to clinical use. Neuropsychiatr. Dis. Treat.11, 2635–2647 (2015).
   PubMed Web of Science ®Google Scholar
• Horacek J , Bubenikova-ValesovaV , KopecekMet al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs20(5), 389–409 (2006).
   PubMed Web of Science ®Google Scholar
• Stip E , TourjmanV. Aripiprazole in schizophrenia and schizoaffective disorder: a review. Clin. Ther.32(Suppl. 1), S3–S20 (2010).
   PubMedGoogle Scholar
• Bargiota SI , BonotisKS , MessinisIE , AngelopoulosNV. The effects of antipsychotics on prolactin levels and women’s menstruation. Schizophr. Res. Treat.2013, 502697 (2013).
   PubMedGoogle Scholar
• Hall TR , HarveyS , ChadwickA. Mechanism of serotonin effects on prolactin and growth hormone secretion in domestic fowl. Acta Endocrinol. (Copenh.)104(3), 266–271 (1983).
   PubMedGoogle Scholar
• Kapur S , LangloisX , VinkenP , MegensAAHP , de CosterR , AndrewsJS. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood–brain disposition: a pharmacological analysis in rats. J. Pharmacol. Exp. Ther.302(3), 1129–1134 (2002).
   PubMed Web of Science ®Google Scholar
• Casey DE , CarsonWH , SahaARet al. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Psychopharmacology (Berl.)166(4), 391–399 (2003).
   PubMed Web of Science ®Google Scholar
• Miura I , ZhangJ-P , HagiKet al. Variants in the DRD2 locus and antipsychotic-related prolactin levels: a meta–analysis. Psychoneuroendocrinology72, 1–10 (2016).
   PubMed Web of Science ®Google Scholar
• Calarge CA , EllingrodVL , AcionLet al. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents: pharmacogenet. Genomics19(5), 373–382 (2009).
   Web of Science ®Google Scholar
• Zhang XR , ZhangZJ , ZhuRX , YuanYG , JenkinsTA , ReynoldsGP. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes. Pharmacogenomics12(8), 1127–1136 (2011).
   PubMed Web of Science ®Google Scholar
• Mihara K , SuzukiA , KondoTet al. Relationship between Taq1A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol. Am. J. Med. Genet.105(3), 271–274 (2001).
   PubMed Web of Science ®Google Scholar
• López-Rodríguez R , RománM , NovalbosJ , PelegrinaML , OchoaD , Abad-SantosF. DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers. J. Clin. Psychopharmacol.31(5), 555–562 (2011).
   PubMed Web of Science ®Google Scholar
• Nagai G , MiharaK , NakamuraAet al. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia: prolactin response to aripiprazole. Psychiatry Clin. Neurosci.66(6), 518–524 (2012).
   PubMed Web of Science ®Google Scholar
• Koller D , BelmonteC , Saiz-RodríguezMet al. Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers. Basic Clin. Pharmacol. Toxicol. (2019).
   Web of Science ®Google Scholar
• Yasui-Furukori N , SaitoM , TsuchimineSet al. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry32(6), 1491–1495 (2008).
   PubMed Web of Science ®Google Scholar
• Lundstrom K , TurpinMP. Proposed Schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the semliki forest virus system. Biochem. Biophys. Res. Commun.225(3), 1068–1072 (1996).
   PubMed Web of Science ®Google Scholar
• Fedorenko OY , LoonenAJM , VyalovaNMet al. Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia. Physiol. Pharmacol., 21(1), 25–33 (2017).
   Google Scholar
• Ivanova SA , OsmanovaDZ , FreidinMBet al. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia. World J. Biol. Psychiatry.18(3), 239–246 (2017).
   PubMed Web of Science ®Google Scholar
• Schoretsanitis G , de LeonJ , DiazFJ. Prolactin levels: sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants. Pharmacogenomics19(10), 815–823 (2018).
   PubMed Web of Science ®Google Scholar
• Tachibana O , YamashimaT , YamashitaJ , TakabatakeY. Immunohistochemical expression of human chorionic gonadotropin and P-glycoprotein in human pituitary glands and craniopharyngiomas. J. Neurosurg.80(1), 79–84 (1994).
   PubMed Web of Science ®Google Scholar
• Hattori S , SudaA , KishidaIet al. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia. BMC Psychiatry18(1), 231 (2018).
   PubMedGoogle Scholar
• Nagasaka Y , OdaK , IwatsuboT , KawamuraA , UsuiT. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood–brain barrier: inhibition of drug transporters by aripiprazole and its metabolite. Biopharm. Drug Dispos.33(6), 304–315 (2012).
   PubMed Web of Science ®Google Scholar